Tag - medicine

 
Menu
Search
 
July 17, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE

Japan Times
WORLD / Science & Health
Dec 7, 2021
New COVID-19 pills offer hope as omicron looms
Two new antiviral pills are coming soon, and are expected to work against all versions of the virus.
Japan Times
COMMENTARY / World
Dec 5, 2021
Who’s afraid of evidence-based policymaking?
As societies struggle to reopen in the shadow of new COVID-19 variants, social experiments are urgently needed to ensure that we implement policies with proven records of success.
Japan Times
WORLD / Science & Health
Dec 3, 2021
Six vaccines show promise as boosters, led by mRNA shots
Researchers tested the vaccines in more than 2,800 volunteers 30 and older who had already received two doses of the AstraZeneca or Pfizer shots.
Japan Times
EDITORIALS
Dec 3, 2021
Omicron is a wake-up call to fix vaccine inequality
The most important factor in COVID-19's evolution and the threat its variants pose is the size of unvaccinated populations and the reservoirs in which they can develop.
Japan Times
JAPAN / FOCUS
Dec 2, 2021
Japan’s drug regulator considers sweeping changes after COVID-19 vaccine delay
After being one of the last major developed nations to approve Pfizer's vaccine, Japan's drug regulator is looking to ease approval requirements for future pandemics.
Japan Times
COMMENTARY / World
Dec 1, 2021
What’s worst about omicron so far is the uncertainty
How should the world respond to omicron? We just have to wait as there is information that we don't yet have. And for many, the waiting itself is the problem.
Japan Times
COMMENTARY / World
Nov 30, 2021
Omicron is the price we pay for vaccine inequality
Amsterdam's main airport went into lockdown recently after 61 passengers on two flights from southern Africa tested positive for the new virus. Japan, Hong Kong and Israel have also reported cases.
Japan Times
JAPAN / Science & Health
Nov 30, 2021
Japanese drugmaker Shionogi considers developing vaccine for omicron variant
The company is currently conducting a final clinical trial of its COVID-19 vaccine, aiming to make it available in March.
Japan Times
COMMENTARY / World
Nov 29, 2021
COVID-19 has changed socialized medicine in Britain forever
How did the U.K. make it through the past 20 months of COVID-19? The private sector's role in delivering publicly funded care needs to be acknowledged.
Japan Times
WORLD / Science & Health
Nov 28, 2021
Moderna says new vaccine for omicron may be ready in early 2022
Moderna's chief medical officer says the company should know about the ability of the current vaccine to provide protection in the next couple of weeks.
Japan Times
COMMENTARY / World
Nov 28, 2021
Can vaccines get rid of long COVID?
The subject of long COVID has also been divisive, with social media full of both support groups and skeptics.
Japan Times
WORLD
Nov 27, 2021
Merck says its antiviral pill is less effective in final analysis
A final analysis of a clinical trial said the antiviral pill reduced the risk of hospitalization and death among high-risk COVID patients by 30%, down from an earlier estimate of 50%.
Japan Times
COMMENTARY / World
Nov 26, 2021
Did AstraZeneca keep Britain safer from COVID-19 than Europe?
It's suggested that Britain's home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
Japan Times
COMMENTARY / World
Nov 24, 2021
Mass COVID-19 testing: Does it save lives?
Would Japan have seen far greater fatalities if it opted for mass COVID-19 testing like other countries rather than just targeting vulnerable group as it did?
Japan Times
JAPAN / Science & Health
Nov 18, 2021
Health ministry to allow faster approval of drugs and vaccines in emergencies
The plan, to be finalized by the end of the year, comes amid criticism that Japan lagged other countries in approving drugs and vaccines to deal with the COVID-19 pandemic.
Japan Times
WORLD / Science & Health
Nov 16, 2021
Pfizer to allow generic versions of its COVID-19 pill in 95 countries
A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.
Japan Times
JAPAN
Nov 13, 2021
COVID cases in Tokyo hit 471,000 as of March — quadruple official tally — study says
Researchers say asymptomatic or mild cases likely behind dramatic undercount in number of coronavirus infections.
Japan Times
COMMENTARY / World
Nov 12, 2021
Why COVID-19 misinformation works
Misinformed people, especially about COVID-19, do not simply have inaccurate information; they are heavily invested in their misconceptions.
Japan Times
WORLD
Nov 9, 2021
Regeneron antibody prevents COVID-19 infections for eight months
The company has asked the U.S. Food and Drug Administration to expand the authorization so the drug can be used to prevent infections.
Japan Times
WORLD / ANALYSIS
Nov 9, 2021
COVID-19 pills no substitute for vaccines, disease experts say
Some experts fear the arrival of oral treatments for the coronavirus may further impede vaccination campaigns.
Who needs AI when you have Hatsune Miku?
Over the first six months of 2024, a handful of songs using Vocaloid singer Hatsune Miku’s voice have enjoyed widespread attention, underlining a global interest in the character and the technology she represents.
Yen’s woes seem too big for even a BOJ hike this month to solve
The Bank of Japan headquarters in Tokyo
China’s economic growth comes in worse than expected
Pedestrians in the Wangfujing shopping area in Beijing on July 11, 2024. China's economic growth in the second quarter was lower than forecast, adding pressure on Chinese leaders to lift confidence at the Chinese Communist Party's third plenum this week.
Kansai airports to increase takeoff and landing slots ahead of Osaka Expo
Kansai International Airport in Izumisano, Osaka Prefecture. The upper limit on the number of takeoff and landing slots at the airport as well as Kobe Airport in Hyogo Prefecture will be raised in spring next year ahead of the 2025 World Exposition in Osaka.
Shooter came within inches of killing Trump, but left few clues as to why
An aerial view shows the stage where Republican presidential candidate and former U.S. President Donald Trump had been standing during an assassination attempt the day before, and the roof of a nearby building where a gunman was shot dead by law enforcement, in Butler, Pennsylvania, on Sunday.
The neurological disorder that 'kills culture'
Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
How to beat Japan’s summer heat in ways better for the planet
Tenugui towels hang up to dry at a dyeing company in Sakai, Osaka Prefecture, on May 8. The durable and versatile tenugui, which many people have in their homes, can be used in many ways to cool one’s body.
After Trump shooting, U.S. presidential race might take a violent turn
United States Secret Service Counter Snipers stand guard on a rooftop during a campaign rally for U.S. President Donald Trump in Avoca, Pennsylvania, in 2020.
No AC this summer? No problem (for me).
Think air conditioning is a requirement for a Tokyo summer? Think again.
She’s paying ¥1 million to help behind the scenes at the Paris Olympics
Mai Tarumi, who previously volunteered at the postponed Tokyo Olympics in 2021, has a travel budget of ¥1 million for her trip to volunteer at the Paris Games.

Podcast

You can often see generations of families enjoying performances together at Fuji Rock Festival.
Japan’s summer music festivals are feeling the heat in more ways than one

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'
By Tomoko Otake

SUSTAINABLE JAPAN

Omron helping firms achieve carbon neutrality
Omron helping firms achieve carbon neutrality

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER